Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Delivering Portable Chest Radiography Through Glass (TG-CXR) Reduces COVID-19 Infection Risk in Hospitals

By HospiMedica International staff writers
Posted on 20 Apr 2021
A study to understand the cost and benefit of adopting portable chest radiography through glass (TG-CXR) at a tertiary care centre during the COVID-19 pandemic has found the novel technique to be particularly beneficial.

A team of two technologists at the Department of Radiology, St. More...
Michael's Hospital, University of Toronto (Toronto, ON, Canada) were trained on the TG-CXR method which has the benefit of allowing one technologist to stay outside of the patient room while operating the portable radiography machine, thus reducing PPE use, decreasing the frequency of radiography machine sanitization and reducing their exposure to potentially infectious patients.

The cost of implementing the technique during the current COVID-19 pandemic was obtained from the department's operational database. The direct cost of routinely used PPE and sanitization materials and the cost of the time taken by the technologists to clean the machine was used to form a quantitative picture of the benefit associated with TG-CXR technique.

The technologists were trained on the TG-CXR method during a 15 minute shift change briefing. This translated to a one-time cost of USD 424.88. There was an average reduction of portable radiography machine downtime of four minutes and 48 seconds per study. The benefit of adopting the TG-CXR technique was USD 9.87 per patient imaged, resulting in a projected net cost savings of USD 51,451.84 per annum. Thus, the study concluded that adoption of the TG-CXR technique during the COVID-19 pandemic involves a minimal one-time cost, but can result in a significant benefit over the year.

"We hope that our findings would encourage policy-makers to implement TG-CXR technique at their institutions when and where possible," the study concluded.

Related Links:
University of Toronto


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.